Donald Balfour Palmer

Title: The Innovations of Donald Balfour Palmer

Introduction

Donald Balfour Palmer is a notable inventor based in Middlesex, GB. He has made significant contributions to the field of biotechnology, particularly in the development of human mini-antibodies for therapeutic applications. With a total of 2 patents, his work has the potential to impact cancer treatment significantly.

Latest Patents

Palmer's latest patents include a groundbreaking invention titled "Human mini-antibody cytotoxic for tumor cells which express the ERBB2 receptor." This invention refers to a fully human mini-antibody (scFv), called Erbicin, which is specific for the receptor ErbB2 and exhibits pharmacological, particularly anti-tumor, activity. The mini-antibody has been obtained from a larger phage display library (Griffin 1.) through panning, which involves affinity selection on antigen carried out on live cells expressing various levels of ErbB2. The invention also encompasses the DNA and amino acid sequences of the antibody, the procedure for isolating it, and its therapeutic applications.

Career Highlights

Throughout his career, Palmer has worked with various companies, including Biotechnol S.A. and Biotecnol S.A. His innovative work in the field of biotechnology has positioned him as a key figure in the development of novel therapeutic agents.

Collaborations

Some of his notable coworkers include Giuseppe D'Alessio and Renata Piccoli. Their collaborative efforts have contributed to the advancements in the research and development of mini-antibodies.

Conclusion

Donald Balfour Palmer's contributions to biotechnology, particularly through his patents on human mini-antibodies, highlight his innovative spirit and dedication to improving cancer therapies. His work continues to inspire advancements in the field.